| Literature DB >> 17849010 |
Ketki D Verkhedkar1, Karthik Raman, Nagasuma R Chandra, Saraswathi Vishveshwara.
Abstract
BACKGROUND: Several types of networks, such as transcriptional, metabolic or protein-protein interaction networks of various organisms have been constructed, that have provided a variety of insights into metabolism and regulation. Here, we seek to exploit the reaction-based networks of three organisms for comparative genomics. We use concepts from spectral graph theory to systematically determine how differences in basic metabolism of organisms are reflected at the systems level and in the overall topological structures of their metabolic networks. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2007 PMID: 17849010 PMCID: PMC1964534 DOI: 10.1371/journal.pone.0000881
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Network properties of the reconstructed metabolic networks of M. tuberculosis, M. leprae and E. coli and the corresponding random networks.
| Property |
|
|
|
|
| |||
| Total no. of reactions (nodes) | 1906 | 1325 | 2080 |
| Total no. of edges | 14,100 | 8,508 | 20,316 |
| Reversible reactions | 209 | 152 | 274 |
| Irreversible reactions | 1488 | 1021 | 1532 |
| No. of metabolites participating in the reactions | 1649 | 1139 | 1633 |
| Total no. of proteins catalyzing the reactions | 1097 | 469 | 1062 |
| No. of currency metabolites eliminated | 102 | 84 | 107 |
|
| |||
| Percentage of nodes belonging to the largest cluster | 73.40 | 76.15 | 73.85 |
| Percentage of ‘orphan’ nodes | 17.00 | 16.30 | 16.39 |
| Highest degree of connections | 72 | 50 | 96 |
| Average path length | 5.58 | 5.48 | 4.94 |
| Clustering co-efficient | 0.01669 | 0.01600 | 0.01614 |
| Degree exponent of the power law degree distribution | 1.3952 | 1.4423 | 1.4093 |
|
| |||
| Percentage of nodes belonging to the largest cluster | 99.94 | 99.85 | 99.99 |
| Percentage of ‘orphan’ nodes | 0.0588 | 0.1487 | 0.0058 |
| Highest degree of connections | 22 | 21 | 27 |
| Average path length | 4.00±0.02 | 4.07±0.03 | 3.61±0.01 |
| Clustering co-efficient | (3.78±0.56) | (4.84±0.89) | (4.67±0.45) |
| Characteristic Scale | 7.40±0.0122 | 6.42±0.0137 | 9.76±0.0134 |
Random networks have been generated using the Erdős-Rényi model, with the same total number of vertices and edge probability as the corresponding reaction networks.
Figure 1A–C: Plots of the degree distributions of nodes in the reaction networks of M. tuberculosis, M. leprae and E. coli.
D–F: Log-log plots of the degree distribution function P(k) versus the degree k. P(k) defines the probability of a given node making exactly k connections in the network. The fit to the curve shows a power law behaviour and has an exponent of ∼1.4 for all three networks. G–I: Representative degree distributions of nodes in random networks generated with the same total number of nodes and edges as the reaction networks of M. tuberculosis, M. leprae and E. coli.
Figure 2Clusters in the reaction networks of M. tuberculosis (A), M. leprae (B) and E. coli (C).
The giant component in the networks comprises 73–76% of the total number of nodes, while 8–10% of the total nodes form other clusters in the networks. The orphan nodes have been eliminated for better visualisation.
Figure 32evc plots for the giant components of the reaction networks of M. tuberculosis (A), M. leprae (B) and E. coli (C).
Plateaus represent sub-clusters of reactions. The giant component in the reaction network of E. coli does not resolve into sub-clusters as indicated by the single plateau in plot C. Arrows indicate plateaus representing the sub-cluster of mycolic acid pathway reactions in the mycobacterial networks.
Examples of sub-clusters in the giant component of the metabolic network of M. tuberculosis.
| 2evc | Node no. | RID | Pathway-ID | Pathway |
| CLUSTER 1 | (SIZE: 12) | |||
| 0.00902 | 552 | R01700 | map00020 | Citrate cycle (TCA cycle) |
| 0.00902 | 1129 | R04231 | map00770 | Pantothenate and CoA biosynthesis |
| 0.00902 | 1130 | R04233 | rn00770 | Pantothenate and CoA biosynthesis |
| 0.00902 | 181 | R00439B | rn00230 | Purine metabolism |
| 0.00902 | 168 | R00429 | rn00230 | Purine metabolism |
| 0.00902 | 278 | R00722B | rn00230 | Purine metabolism |
| 0.00902 | 173 | R00434 | rn00230 | Purine metabolism |
| 0.00902 | 118 | R00332B | rn00230 | Purine metabolism |
| 0.00902 | 164 | R00416B | map00530 | Aminosugars metabolism |
| 0.00902 | 331 | R00896 | rn00272 | Cysteine metabolism |
| 0.00902 | 200 | R00480 | rn00260 | Gly, Ser and Thr metabolism |
| 0.00902 | 443 | R01214F | rn00280 | Val, Leu, Ile degradation |
| CLUSTER 2 | (SIZE: 11) | |||
| 0.00921 | 483 | R01343F | map00220 | Urea cycle and metabolism of amino groups |
| 0.00921 | 453 | R01248F | rn00220 | Urea cycle and metabolism of amino groups |
| 0.00921 | 455 | R01251F | rn00220 | Urea cycle and metabolism of amino groups |
| 0.00921 | 999 | R03646B | rn00330 | Arg and Pro metabolism |
| 0.00921 | 457 | R01253 | rn00330 | Arg and Pro metabolism |
| 0.00921 | 834 | R02788 | rn00300 | Lys biosynthesis |
| 0.00921 | 135 | R00376F | rn00230 | Purine metabolism |
| 0.00921 | 612 | R01857B | rn00230 | Purine metabolism |
| 0.00921 | 701 | R02235F | rn00790 | Folate biosynthesis |
| 0.00921 | 703 | R02236F | rn00670 | One carbon pool by folate |
| 0.00921 | 1542 | R05688 | rn00100 | Biosynthesis of steroids |
| CLUSTER 3 | (SIZE: 10) | |||
| 0.00675 | 1204 | R04536B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1206 | R04543B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1343 | R04958B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1346 | R04961B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1349 | R04964B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1351 | R04966B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1340 | R04955B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1180 | R04429B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1202 | R04534B | rn00061 | Fatty acid biosynthesis |
| 0.00675 | 1338 | R04953B | rn00061 | Fatty acid biosynthesis |
| CLUSTER 4 | (SIZE:24) | |||
| −0.07038 | 1810 | MAP123 | fasII | Mycolic acid pathway |
| −0.07038 | 1812 | MAP125 | fasII | Mycolic acid pathway |
| −0.07038 | 1813 | MAP126 | fasII | Mycolic acid pathway |
| −0.07038 | 1814 | MAP127 | fasII | Mycolic acid pathway |
| −0.07038 | 1816 | MAP129 | fasII | Mycolic acid pathway |
| −0.07038 | 1794 | MAP107 | fasII | Mycolic acid pathway |
| −0.07038 | 1818 | MAP131 | fasII | Mycolic acid pathway |
| −0.07038 | 1819 | MAP132 | fasII | Mycolic acid pathway |
| −0.07038 | 1820 | MAP133 | fasII | Mycolic acid pathway |
| −0.07038 | 1822 | MAP135 | fasII | Mycolic acid pathway |
| −0.07038 | 1824 | MAP137 | fasII | Mycolic acid pathway |
| . | ||||
| . | ||||
| . | ||||
| −0.07038 | 1825 | MAP138 | fasII | Mycolic acid pathway |
| −0.07038 | 1826 | MAP139 | fasII | Mycolic acid pathway |
| −0.07038 | 1795 | MAP108 | fasII | Mycolic acid pathway |
In the RID, F indicates the reaction proceeding in the forward direction, and B indicates the reaction proceeding in the backward direction.
Top fifteen hubs in M. tuberculosis that are absent in the metabolome of humans.
| Rank as a unique hub | Rank as a GS hub | Node no. | Hub RID | E.C. No. of catalyzing enzyme | Name of Enzyme | Pathway(s) for which the enzyme is required |
| 1 | 3 | 368 | R00986 | 4.1.3.27 | Anthranilate synthase | Phenylalanine, tyrosine and tryptophan biosynthesis |
| 2 | 4 | 482 | R01339F | 2.6.1.- | Transferases, transaminases | Nitrogen metabolism |
| 3 | 8 | 1197 | R04475B | 2.6.1.17 | Succinyldiaminopimelate aminotransferase | Lysine biosynthesis |
| 4 | 12 | 197 | R00457B | 2.6.1.36 | Transferases, Transaminases | Lysine biosynthesis |
| 5 | 14 | 717 | R02283B | 2.6.1.11 | Acetylornithine transaminase | Urea cycle and metabolism of amino groups |
| 6 | 28 | 160 | R00411 | 3.5.1.- | Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds in linear amides | Arginine and proline metabolism |
| 7 | 35 | 714 | R02282f | 2.3.1.35 | Glutamate N-acetyltransferase | Urea cycle and metabolism of amino groups |
| 8 | 48 | 19 | R00114 | 1.4.1.13 | L-glutamate synthase | Glutamate metabolism, Nitrogen metabolism |
| 9 | 49 | 562 | R01716 | 6.3.5.8 | Aminodeoxychorismate synthase | Folate biosynthesis |
| 10 | 54 | 87 | R00260F | 5.1.1.3 | Glutamate racemase | Glutamate metabolism, D-Glutamine and D-glutamate metabolism |
| 11 | 55 | 1440 | R05225 | 6.3.5.10 | Cobyric acid synthase | Porphyrin and chlorophyll metabolism |
| 12 | 64 | 1439 | R05224 | 6.3.5.9 | Hydrogenobyrinic acid a,c-diamide synthase (glutamine-hydrolysing) | Porphyrin and chlorophyll metabolism |
| 13 | 83 | 1707 | R06860 | 2.5.1.64 | 2-succinyl-6-hydroxy-2,4-cyclohexadiene | Ubiquinone biosynthesis |
| 14 | 85 | 1458 | R05320 | 1.14.11.17 | Taurine dioxygenase | Taurine and hypotaurine metabolism |
| 15 | 86 | 442 | R01197 | 1.2.7.3 | 2-oxoglutarate synthase | Citrate cycle |
| . | ||||||
| . | ||||||
| 38 | 172 | 1692 | MAP005 | - | Acyl carrier protein-fatty acid synthase I (ACP-FAS) | Mycolic acid pathway |
ACP-FAS enzyme involved in the fifth reaction of the mycolic acid pathway ranks as the 38th unique hub in M. tuberculosis.
Shortest path between steps in glycolytic pathway.
| Steps in terms of RIDs: | |
| R00959F→R02740F→R01830F→R01826F→R00658F | |
| R00959 (EC 5.4.2.2) | D-Glucose-1-phosphate→alpha-D-Glucose-6-phosphate |
| R02740 (EC 5.3.1.9) | alpha-D-Glucose-6-phosphate→beta-D-Fructose-6-phosphate |
| R01830 (EC 2.2.1.1) | beta-D-Fructose-6-phosphate+(2R)-2-Hydroxy-3-(phosphonooxy)-propanal→D-Erythrose-4-phosphate+D-Xylulose-5-phosphate |
| R01826 (EC 2.5.1.54) | Phosphoenolpyruvate+D-Erythrose-4-phosphate+H2O→2-Dehydro-3-deoxy-D-arabino-heptonate-7-phosphate+Orthophosphate |
| R00658 (EC 4.2.1.11) | 2-Phospho-D-glycerate→Phosphoenolpyruvate+H2O |